195 related articles for article (PubMed ID: 38343540)
1. EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells.
Cuenca-Escalona J; Subtil B; Garcia-Perez A; Cambi A; de Vries IJM; Flórez-Grau G
Front Immunol; 2024; 15():1355769. PubMed ID: 38343540
[TBL] [Abstract][Full Text] [Related]
2. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.
Francica BJ; Holtz A; Lopez J; Freund D; Chen A; Wang D; Powell D; Kipper F; Panigrahy D; Dubois RN; Whiting CC; Prasit P; Dubensky TW
Cancer Res Commun; 2023 Aug; 3(8):1486-1500. PubMed ID: 37559947
[TBL] [Abstract][Full Text] [Related]
3. PGE2-EP4 signaling steers cDC2 maturation toward the induction of suppressive T-cell responses.
Cuenca-Escalona J; Flórez-Grau G; van den Dries K; Cambi A; de Vries IJM
Eur J Immunol; 2024 Mar; 54(3):e2350770. PubMed ID: 38088451
[TBL] [Abstract][Full Text] [Related]
4. PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer.
Akbari B; Soltantoyeh T; Shahosseini Z; Jadidi-Niaragh F; Hadjati J; Brown CE; Mirzaei HR
Front Immunol; 2023; 14():1209572. PubMed ID: 37457723
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-Derived Suppressor Cells Dampen Airway Inflammation Through Prostaglandin E2 Receptor 4.
van Geffen C; Deißler A; Beer-Hammer S; Nürnberg B; Handgretinger R; Renz H; Hartl D; Kolahian S
Front Immunol; 2021; 12():695933. PubMed ID: 34322123
[TBL] [Abstract][Full Text] [Related]
6. Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists.
Bödder J; Kok LM; Fauerbach JA; Flórez-Grau G; de Vries IJM
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674907
[TBL] [Abstract][Full Text] [Related]
7. Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells.
Obermajer N; Muthuswamy R; Lesnock J; Edwards RP; Kalinski P
Blood; 2011 Nov; 118(20):5498-505. PubMed ID: 21972293
[TBL] [Abstract][Full Text] [Related]
8. Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4.
Holt DM; Ma X; Kundu N; Collin PD; Fulton AM
J Immunother; 2012; 35(2):179-88. PubMed ID: 22306906
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
[TBL] [Abstract][Full Text] [Related]
10. T cell-intrinsic prostaglandin E
Lee J; Aoki T; Thumkeo D; Siriwach R; Yao C; Narumiya S
J Allergy Clin Immunol; 2019 Feb; 143(2):631-643. PubMed ID: 29935220
[TBL] [Abstract][Full Text] [Related]
11. The prostaglandin EP4 receptor is a master regulator of the expression of PGE
Kashmiry A; Tate R; Rotondo G; Davidson J; Rotondo D
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1297-1304. PubMed ID: 30053598
[TBL] [Abstract][Full Text] [Related]
12. A RIPK3-PGE
Yan G; Zhao H; Zhang Q; Zhou Y; Wu L; Lei J; Wang X; Zhang J; Zhang X; Zheng L; Du G; Xiao W; Tang B; Miao H; Li Y
Cancer Res; 2018 Oct; 78(19):5586-5599. PubMed ID: 30012671
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Signaling Modalities of Prostaglandin E2 Receptors EP2 and EP4 Reveals Crosstalk and a Role for Microtubules.
Vleeshouwers W; van den Dries K; de Keijzer S; Joosten B; Lidke DS; Cambi A
Front Immunol; 2020; 11():613286. PubMed ID: 33643295
[TBL] [Abstract][Full Text] [Related]
14. 15-Keto-PGE
Endo S; Suganami A; Fukushima K; Senoo K; Araki Y; Regan JW; Mashimo M; Tamura Y; Fujino H
J Biol Chem; 2020 Sep; 295(38):13338-13352. PubMed ID: 32727851
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity.
Mao Y; Sarhan D; Steven A; Seliger B; Kiessling R; Lundqvist A
Clin Cancer Res; 2014 Aug; 20(15):4096-106. PubMed ID: 24907113
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells.
Hsu HH; Lin YM; Shen CY; Shibu MA; Li SY; Chang SH; Lin CC; Chen RJ; Viswanadha VP; Shih HN; Huang CY
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587064
[TBL] [Abstract][Full Text] [Related]
17. Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E
Mangelsen E; Rothe M; Schulz A; Kourpa A; Panáková D; Kreutz R; Bolbrinker J
Cells; 2020 May; 9(5):. PubMed ID: 32438662
[TBL] [Abstract][Full Text] [Related]
18. Metabolic regulation by prostaglandin E
Robb CT; Zhou Y; Felton JM; Zhang B; Goepp M; Jheeta P; Smyth DJ; Duffin R; Vermeren S; Breyer RM; Narumiya S; McSorley HJ; Maizels RM; Schwarze JKJ; Rossi AG; Yao C
Allergy; 2023 Mar; 78(3):714-730. PubMed ID: 36181709
[TBL] [Abstract][Full Text] [Related]
19. Endogenous prostaglandin E
Samuchiwal SK; Balestrieri B; Raff H; Boyce JA
J Biol Chem; 2017 May; 292(20):8195-8206. PubMed ID: 28341741
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
